Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Socioeconomic Status Impact on Chronic GVHD

Biol Blood Marrow Transplant; ePub 2017 Oct 12; Hamilton, et al

Certain socioeconomic factors were linked with improved chronic graft-versus host disease (GVHD) symptom scores in a study involving 421 individuals. However, they had no impact on survival and non-relapse mortality. Participants had chronic GVHD. Investigators looked at the impact income, education, marital status, and work status had on outcomes and non-relapse and overall mortality. Among the results:

  • Higher income, ability to work, and having a partner were linked with better chronic GVHD symptom scores.
  • Higher income, level of education, and ability to work were significantly linked with better quality of life and improved activity.
  • Higher income and ability to return to work were both significantly linked with better chronic GVHD scores.
  • Those unable to return to work experienced worse overall mortality.
  • None of the socioeconomic status indicators were linked with non-relapse mortality.
  • Income, race, and education did not impact survival.

Citation:

Hamilton B, Rybicki L, Arai S, et al. Association of socioeconomic status with chronic graft-versus-host disease outcomes. [Published online ahead of print October 12, 2017]. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2017.10.009.

This Week's Must Reads

HCV and Increased Risk of Atherosclerosis, Hepatol Int; ePub 2018 Feb 8; Bridge, et al

Chronic HCV & Early HIV Viral Response to ART, AIDS; ePub 2018 Jan 13; Willis, Cole, et al

Impact of DM/HBV Coinfection in Patients with HCV, J Gastroenterol Hepatol; ePub 2018 Jan 26; Subramaniam, et al

Prevalence of HCV and Route of Transmission, J Viral Hepat; 2018 Feb; Wong, Lee, Ng, et al

Liver Fibrosis & Microbial Translocation in HIV/HCV, J Infect Dis; ePub 2018 Jan 3; Reid, et al

Must Reads in Hematologic Malignancies

Prognostic Score System for Patients with PMF, J Clin Oncol; ePub 2017 Dec 9; Gugliemelli, et al

These Patients Are More Apt to Be Depressed, Ann Hematol; ePub 2017 Dec 7; Shreders, et al

Survival Length Shortest in These Patients with MF, Eur J Haematol; ePub 2017 Dec 11; Masarova, et al

The Value of Ruxolitinib Before and After AlloSCT, Blood; ePub 2017 Dec 7; Poulose, Malysz, et al

Tyrosine Kinase Inhibitors in Pediatric ALL, Hematology 2017; 2017 Dec 8; Silverman, et al